Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE

Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE

Objective We compared the physician-assessed diagnostic likelihood of SLE resulting from standard diagnosis laboratory testing (SDLT) to that resulting from multianalyte assay panel (MAP) with cell-bound complement activation products (MAP/CB-CAPs), which reports a two-tiered index test result havin...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel J Wallace, Thierry Dervieux, Arezou Khosroshahi, Claudia Ibarra, Tyler O'Malley, Elena Massarotti, Roberta Vezza Alexander, Mehrnaz Hojjati, Konstantinos Loupasakis, Jeffrey Alper, Yvonne Sherrer, Maria Fondal, Rajesh Kataria, Tami Powell, Sonali Narain, Arthur Weinstein
Format: Article
Language:English
Published: BMJ Publishing Group 2019-12-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/6/1/e000349.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://lupus.bmj.com/content/6/1/e000349.full

Similar Items